A partial reduction of Drp1 improves cognitive behavior and enhances mitophagy, autophagy and dendritic spines in a transgenic Tau mouse model of Alzheimer disease is a research paper published in Human Molecular Genetics (2021). On theSindex it has a DataRank of 1.4. It has been cited 64 times, with 45 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.626
From this paper's citation signal
Citation Network Contribution
0.800
From 39 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 45 citers.
National Institutes of Health
Grant: AG042178
National Institutes of Health
Grant: AG047812
National Institutes of Health
Grant: NS105473
National Institutes of Health
Grant: AG060767
National Institutes of Health
Grant: AG069333
National Institutes of Health
Grant: AG066347
NINDS NIH HHS
Grant: R01 NS105473
NIA NIH HHS
Grant: R01 AG042178
NIA NIH HHS
Grant: R01 AG047812
NIA NIH HHS
Grant: R01 AG069333
NIA NIH HHS
Grant: R56 AG060767
NIA NIH HHS
Grant: R56 AG066347
FWCI
5.71
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 8 of Calcineurin inhibition protects against dopamine toxicity and attenuates behavioral decline in a Parkinson’s disease model
Additional file 8 of Calcineurin inhibition protects against dopamine toxicity and attenuates behavioral decline in a Parkinson’s disease model
Additional file 7 of Calcineurin inhibition protects against dopamine toxicity and attenuates behavioral decline in a Parkinson’s disease model
Additional file 6 of Calcineurin inhibition protects against dopamine toxicity and attenuates behavioral decline in a Parkinson’s disease model
Additional file 7 of Calcineurin inhibition protects against dopamine toxicity and attenuates behavioral decline in a Parkinson’s disease model
Additional file 5 of Calcineurin inhibition protects against dopamine toxicity and attenuates behavioral decline in a Parkinson’s disease model
Additional file 5 of Calcineurin inhibition protects against dopamine toxicity and attenuates behavioral decline in a Parkinson’s disease model
Additional file 6 of Calcineurin inhibition protects against dopamine toxicity and attenuates behavioral decline in a Parkinson’s disease model
Additional file 4 of Calcineurin inhibition protects against dopamine toxicity and attenuates behavioral decline in a Parkinson’s disease model
Additional file 3 of Calcineurin inhibition protects against dopamine toxicity and attenuates behavioral decline in a Parkinson’s disease model
Additional file 4 of Calcineurin inhibition protects against dopamine toxicity and attenuates behavioral decline in a Parkinson’s disease model
Additional file 3 of Calcineurin inhibition protects against dopamine toxicity and attenuates behavioral decline in a Parkinson’s disease model
Additional file 2 of Calcineurin inhibition protects against dopamine toxicity and attenuates behavioral decline in a Parkinson’s disease model
Additional file 1 of Calcineurin inhibition protects against dopamine toxicity and attenuates behavioral decline in a Parkinson’s disease model
Additional file 2 of Calcineurin inhibition protects against dopamine toxicity and attenuates behavioral decline in a Parkinson’s disease model
Additional file 1 of Calcineurin inhibition protects against dopamine toxicity and attenuates behavioral decline in a Parkinson’s disease model